comparemela.com

Latest Breaking News On - Fusion pharmaceuticals trading - Page 1 : comparemela.com

B Riley Downgrades Fusion Pharmaceuticals (NASDAQ:FUSN) to Neutral

B. Riley lowered shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Wednesday morning, Marketbeat reports. B. Riley currently has $23.00 price target on the stock, up from their previous price target of $13.00. Other equities research analysts have also […]

Fusion Pharmaceuticals (NASDAQ:FUSN) Receives Hold Rating from Jefferies Financial Group

Jefferies Financial Group reaffirmed their hold rating on shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) in a research report report published on Tuesday, Marketbeat reports. They currently have a $21.00 price target on the stock, up from their prior price target of $10.00. FUSN has been the topic of several other reports. William Blair […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.